Molecular Dynamic Simulation Analysis on the Inclusion Complexation of Plumbagin with β-Cyclodextrin Derivatives in...

Area of Science:

• Pharmaceutical Science
• Supramolecular Chemistry
• Computational Chemistry

Background:

• Stable encapsulation of active compounds is crucial for drug efficacy and shelf-life.
• Cyclodextrins (CDs) are widely used due to their ability to form inclusion complexes.
• Plumbagin is a bioactive compound with therapeutic potential.

Purpose of the Study:

• To investigate the molecular interactions and stability of plumbagin inclusion complexes with β-cyclodextrin (BCD) and its derivatives.
• To identify the optimal cyclodextrin derivative for plumbagin encapsulation.
• To understand the dynamic behavior of plumbagin within the cyclodextrin cavity.

Main Methods:

• Molecular dynamics (MD) simulations were employed.
• GLYCAM-06 and AMBER force fields were utilized.
• Simulations were conducted in aqueous solution at 4 °C.

Main Results:

• 2-O-monohydroxypropyl-β-cyclodextrin (HPBCD) demonstrated the most stable host-guest binding with plumbagin.
• Plumbagin's methyl group preferentially oriented towards the wider rim of the HPBCD cavity.
• The simulations confirmed the potential for stable complex formation.

Conclusions:

• HPBCD is identified as a superior encapsulation agent for plumbagin.
• HPBCD facilitates stable plumbagin preservation, extending storage life.
• HPBCD offers potential for developing slow-release formulations of plumbagin.